Celsius (CELH) to Release Earnings on Tuesday

Celsius (NASDAQ:CELH - Get Free Report) is set to announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.20 per share for the quarter. Investors interested in registering for the company's conference call can do so using this link.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $347.44 million for the quarter, compared to the consensus estimate of $326.77 million. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The company's revenue for the quarter was up 95.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.01 EPS. On average, analysts expect Celsius to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Celsius Stock Up 1.5 %

NASDAQ CELH traded up $1.07 during trading on Wednesday, hitting $72.34. The company's stock had a trading volume of 3,095,165 shares, compared to its average volume of 4,633,219. The firm has a 50 day moving average price of $80.34 and a 200 day moving average price of $65.26. The firm has a market cap of $16.71 billion, a P/E ratio of 93.54, a price-to-earnings-growth ratio of 2.15 and a beta of 1.86. Celsius has a 52 week low of $32.29 and a 52 week high of $99.62.

Insiders Place Their Bets

In other Celsius news, major shareholder Deborah Desantis sold 67,063 shares of the business's stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $50.28, for a total value of $3,371,927.64. Following the transaction, the insider now owns 30,321,589 shares of the company's stock, valued at $1,524,569,494.92. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, major shareholder Dean Desantis sold 100,000 shares of the company's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the transaction, the insider now owns 219,257 shares of the company's stock, valued at $20,993,857.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Deborah Desantis sold 67,063 shares of the company's stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $50.28, for a total value of $3,371,927.64. Following the transaction, the insider now directly owns 30,321,589 shares in the company, valued at approximately $1,524,569,494.92. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,253,278 shares of company stock valued at $83,587,047. 2.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

CELH has been the topic of a number of research reports. Morgan Stanley restated an "equal weight" rating and set a $75.00 price objective on shares of Celsius in a research report on Wednesday, March 27th. Roth Mkm boosted their price objective on Celsius from $90.00 to $105.00 and gave the company a "buy" rating in a research report on Thursday, March 14th. Piper Sandler boosted their price objective on Celsius from $76.00 to $90.00 and gave the company an "overweight" rating in a research report on Friday, March 1st. Maxim Group boosted their price objective on Celsius from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Monday, April 1st. Finally, UBS Group boosted their price objective on Celsius from $73.00 to $99.00 and gave the company a "buy" rating in a research report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $85.10.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.